Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 12.43T | 10.89T | 8.43T | 5.25T | 5.33T |
Gross Profit | 7.03T | 5.38T | 5.38T | 4.37T | 4.04T |
EBITDA | 2.97T | 2.41T | 1.90T | 1.85T | 1.40T |
Net Income | 1.86T | 1.49T | 1.12T | 1.13T | 777.02B |
Balance Sheet | |||||
Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Cash, Cash Equivalents and Short-Term Investments | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Total Debt | 89.40T | 25.75T | 47.28T | 19.11T | 18.09T |
Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Stockholders Equity | 20.52T | 19.59T | 17.23T | 17.02T | 16.80T |
Cash Flow | |||||
Free Cash Flow | -450.29B | -10.31T | 13.03T | 9.25T | 34.51T |
Operating Cash Flow | 6.42B | -9.84T | 13.43T | 9.64T | 34.90T |
Investing Cash Flow | -186.95B | -1.27T | -10.68T | -2.20T | -10.14T |
Financing Cash Flow | -861.12B | 8.31B | -977.14B | -875.97B | -436.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $218.14B | 11.60 | 10.83% | 7.59% | -1.91% | -6.79% | |
78 Outperform | $125.21B | 9.09 | 13.25% | 0.41% | 0.26% | 19.35% | |
78 Outperform | $262.42B | 13.82 | 11.51% | 1.99% | 0.22% | 19.89% | |
76 Outperform | $149.91B | 12.66 | 9.18% | 2.64% | 5.39% | 20.82% | |
73 Outperform | $174.54B | 13.82 | 6.64% | 2.42% | 0.52% | 89.25% | |
73 Outperform | $94.02B | 12.24 | 7.92% | 0.17% | 0.23% | 18.12% | |
61 Neutral | C$14.93B | 6.47 | 22.28% | 5.80% | 30.07% | -22.51% |